In the present case–control study we analysed the frequency of SP-B intron 4 variants in patients with lung cancer and demonstrated an increase of gene variants in lung cancer patients with a high significant difference in the frequency between healthy persons and patients with squamous cell lung cancer. The gene discussed is SFTPB; the disease is lung cancer.